295 related articles for article (PubMed ID: 32751581)
1. Innovative HBV Animal Models Based on the Entry Receptor NTCP.
Wettengel JM; Burwitz BJ
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751581
[TBL] [Abstract][Full Text] [Related]
2. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
4. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
[TBL] [Abstract][Full Text] [Related]
5. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
Fukano K; Oshima M; Tsukuda S; Aizaki H; Ohki M; Park SY; Wakita T; Wakae K; Watashi K; Muramatsu M
J Virol; 2021 Nov; 95(24):e0093821. PubMed ID: 34613794
[TBL] [Abstract][Full Text] [Related]
6. NTCP opens the door for hepatitis B virus infection.
Yan H; Liu Y; Sui J; Li W
Antiviral Res; 2015 Sep; 121():24-30. PubMed ID: 26071008
[TBL] [Abstract][Full Text] [Related]
7. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
Elife; 2012 Nov; 3():. PubMed ID: 25409679
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 inhibits HBV entry through NTCP down regulation.
Bouezzedine F; Fardel O; Gripon P
Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
[TBL] [Abstract][Full Text] [Related]
9. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
10. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
Yan H; Li W
Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
[TBL] [Abstract][Full Text] [Related]
11. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
Elife; 2012 Nov; 1():e00049. PubMed ID: 23150796
[TBL] [Abstract][Full Text] [Related]
12. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.
Shimura S; Watashi K; Fukano K; Peel M; Sluder A; Kawai F; Iwamoto M; Tsukuda S; Takeuchi JS; Miyake T; Sugiyama M; Ogasawara Y; Park SY; Tanaka Y; Kusuhara H; Mizokami M; Sureau C; Wakita T
J Hepatol; 2017 Apr; 66(4):685-692. PubMed ID: 27890789
[TBL] [Abstract][Full Text] [Related]
14. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin Plays a Role in Hepatitis B Virus Entry Through Affecting Glycosylated Sodium-Taurocholate Cotransporting Polypeptide Distribution.
Hu Q; Zhang F; Duan L; Wang B; Ye Y; Li P; Li D; Yang S; Zhou L; Chen W
Front Cell Infect Microbiol; 2020; 10():74. PubMed ID: 32175289
[TBL] [Abstract][Full Text] [Related]
16. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan.
Somiya M; Liu Q; Yoshimoto N; Iijima M; Tatematsu K; Nakai T; Okajima T; Kuroki K; Ueda K; Kuroda S
Virology; 2016 Oct; 497():23-32. PubMed ID: 27420796
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S
J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors.
Meredith LW; Hu K; Cheng X; Howard CR; Baumert TF; Balfe P; van de Graaf KF; Protzer U; McKeating JA
J Gen Virol; 2016 Jan; 97(1):121-127. PubMed ID: 26474824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
